๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Novel biologically based therapies for multiple myeloma

โœ Scribed by Nikhil C. Munshi; Teru Hideshima; Dharminder Chauhan; Paul Richardson; Kenneth C. Anderson

Publisher
Carden Jennings Publishing
Year
2002
Tongue
English
Weight
323 KB
Volume
76
Category
Article
ISSN
0925-5710

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Novel Therapies in Multiple Myeloma
Novel Therapies in Multiple Myeloma
โœ Seema Singhal; Jayesh Mehta ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› Carden Jennings Publishing ๐ŸŒ English โš– 183 KB
Future drug developments in multiple mye
Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies
โœ Gareth Morgan ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 214 KB

The introduction of thalidomide, lenalidomide, and bortezomib has changed the way that multiple myeloma (MM) is treated and has greatly improved survival outcomes. These novel agents are often used in combination with conventional drugs, such as dexamethasone, to optimize clinical responses; however

Combination therapy for multiple myeloma
Combination therapy for multiple myeloma
โœ Dr. Raymond Alexanian; Sydney Salmon; John Bonnet; Edmund Gehan; Arthur Haut; Ja ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 588 KB
Thromboembolic events with lenalidomide-
Thromboembolic events with lenalidomide-based therapy for multiple myeloma
โœ Smitha Patiyil Menon; S. Vincent Rajkumar; Martha Lacy; Patrizia Falco; Antonio ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 87 KB

## Abstract ## BACKGROUND. The purpose was to evaluate the incidence and risk factors of thromboembolism associated with lenalidomide therapy in newly diagnosed myeloma. ## METHODS. A pooled analysis was performed of patients with previously untreated multiple myeloma enrolled in clinical trials